1. Home
  2. HROW

as of 11-28-2025 12:39pm EST

$41.34
+$0.04
+0.10%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Chart Type:
Time Range:
Founded: 1998 Country:
United States
United States
Employees: N/A City: NASHVILLE
Market Cap: 1.4B IPO Year: N/A
Target Price: $68.86 AVG Volume (30 days): 716.4K
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.14 EPS Growth: N/A
52 Week Low/High: $20.85 - $50.72 Next Earning Date: 11-10-2025
Revenue: $250,042,000 Revenue Growth: 47.83%
Revenue Growth (this year): 43.92% Revenue Growth (next year): 41.22%

AI-Powered HROW Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 70.55%
70.55%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Harrow Inc. News

HROW Breaking Stock News: Dive into HROW Ticker-Specific Updates for Smart Investing

All HROW News

Share on Social Networks: